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Nosocomial candidemia: A threat beyond nosocomial bacterial
infections in intensive care units
Emine ALP MEŞE1, Çiğdem AĞKUŞ1, Ramazan COŞKUN2, Gökhan METAN1,
Ayşe Nedret KOÇ3, Murat SUNGUR2, Mehmet DOĞANAY1

Candida bloodstream infections (BSI) have become an increasing cause of BSI in intensive care
units (ICUs). The increasing incidence of nosocomial infections and multidrug-resistant bacteria
in ICUs prolong hospitalization and cause prolonged exposure to multiple broad-spectrum
antibiotics and invasive procedures. As a result of these risk factors, candidemia becomes a major
threat for ICU patients. Moreover, the cause of candidemia has shifted from Candida albicans to
non-albicans species, which causes problems in therapy (1,2).
We conducted a retrospective chart review of ICU patients who had candidemia between 2003
and 2009. The aim was to assess the change in the incidence of candidemia over 7 years and to
determine the distribution of Candida species, risk factors for candidemia, and mortality rates.
The study was carried out at the Erciyes University Hospital. We performed retrospective
laboratory-based surveillance from January 2003 to December 2009 in 7 adult (>16 years) ICUs
(general surgery, medical, anesthesiology, neurosurgery, pulmonary, coronary, and cardiovascular
surgery ICU). The hospital had an automated blood culture system (BACTEC) and data were
recorded in an electronic database. Patient chart reviews were performed in order to identify
clinically relevant episodes and to determine the demographic and epidemiologic characteristics
of patients. Nosocomial candidemia was defined according to the criteria outlined by the Centers
for Disease and Control (3).
To calculate incidence rates, the numbers of patient-days were collected. Incidence rates were
calculated as the number of nosocomial infection episodes per 1000 patient-days and candidemia
episodes per 10,000 patient-days. Data were entered and analyzed using SPSS 15.0 (SPSS, Inc.
Chicago, IL, USA). Categorical data were analyzed using chi-square or Fisher’s exact tests, as
appropriate, and continuous variables were compared using Student’s t tests. P values <0.05 were
accepted as statistically significant.
During the period 2003-2009, a total of 124 cases of candidemia were detected, for an overall
incidence of 16.1 per 10,000 patient-days (Table 1). All patients had had a single episode. As
shown in Table 2, the incidence rate of candidemia in ICUs ranged from 0.8 to 18 per 10,000
patient-days/year and increased during the 7 years. The high incidence was in the general surgery
ICU (20.3/10,000 patient-days) and medical ICU (18.9/10,000 patient-days). Demographic and
clinical characteristics of 124 candidemia episodes are shown in Table 1. The length of stay in the
ICU and hospital was long and 98% of patients had had at least one nosocomial infection and
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Table 1. Clinical characteristics of 124 adult episodes of candidemia.
Variable
Incidence per 10,000 patient days
Distribution of cases in ICU
General surgery
Medical
Anesthesiology
Neurosurgery
Pulmonary
Coronary
Cardiovascular surgery
Age (years; mean ± SD)
Male gender

No. (%)
16.1
Incidence per 10,000 patient days
20.3
18.9
11.9
4.4
7.8
4.5
1.8
60.43 ± 15.81
55 (45)

Duration of hospitalization before candidemia (days; mean ± SD)

22.62 ± 16.45

Duration from admission in ICU before candidemia (days; mean ± SD)

19.78±17.01

Underlying disease
Diabetes mellitus
Coronary artery disease
Gastrointestinal bleeding
Chronic lung disease
Malignancy
Congestive heart failure
Chronic renal failure
Trauma
Cerebrovascular disease
Cirrhosis
Myasthenia gravis
Transplantation

29 (23)
23 (19)
23 (19)
22 (18)
21 (17)
16 (13)
10 (8)
10 (8)
9 (7)
4 (3)
2 (2)
1 (0.8)

Steroid therapy

26 (21)

Previous nosocomial infection

121 (98)

Previous antibiotic therapy

121 (98)

Bacteremia

84 (69)

Invasive procedures
Foley catheter
Central venous catheterization
Endotracheal tube
Tracheostomy
Drainage tube
Total parenteral nutrition
Operation
Gastrointestinal
Others
Previous antibiotic therapy
Carbapenems
Glycopeptide
Cephalosporin
Quinolone
Piperacillin/tazobactam
Ampicillin/sulbactam
Aminoglycoside
Tigecycline
Metronidazol
Clindamycin
Trimetoprim/sulfamethoxazole
Penicillin
Clarithromycin
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116 (94)
113 (91)
107 (86)
61 (49)
58 (47)
102 (82)
75 (61)
48
27
83
58
54
36
36
29
29
10
6
6
1
1
1
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Table 2. Incidence and distribution of candidemia between 2003 and 2009 at Erciyes University Hospital intensive care units expressed
in number and percentage of isolates.

*

Incidence density of NI (n/1000 patient-days)
Total candidemia
Incidence of candidemia/10,000 patient-days

2003

2004

2005

2006

2007

2008

2009

34.2

33.1

39.1

36.7

40.2

46.5

44.2

1

2

9

27

35

31

19

0.8

1.7

6.6

17

18

15

8.7

1

2

3

12

23

18

5

Candida species
Not typed (n = 63)
C. albicans (n = 26)

0

0

2

6

4

6

8

C. parapsilosis (n = 27)

0

0

4

8

6

5

4

C. tropicalis (n = 5)

0

0

0

0

1

2

2

C. glabrata (n = 2)

0

0

0

1

1

0

0

C. kefyr (n = 1)

0

0

0

0

0

0

0

*Nosocomial infection

antibiotic usage before candidemia. Furthermore,
84 (69%) of these patients had had bacteremia
before candidemia. All of the patients had had at
least one invasive procedure, and urinary catheter
and central venous catheter were the most prevalent
procedures. Seventy-five (61%) patients had had
an operation, and 64% of these patients had had a
gastrointestinal operation. Total parenteral nutrition
had been given in 82% of the patients. Most of the
candidemia episodes were defined as primary (n =
114, 92%) and sources of candidemia episodes were
catheter (n = 7), urinary (n = 6), wound (n = 3), and
lung (n = 1). C. albicans (n = 26) and C. parapsilosis
(n = 27) were the most prevalent species (Table 2).
In the comparison of demographic characteristics,
risk factors, and mortality for these 2 species, no
statistically significant difference was identified.
Except for 2 C. glabrata isolates, all Candida isolates
were susceptible to all antifungals; fluconazole was
used for the susceptible isolates and amphotericin B
was used for the azole-resistant isolates. The crude
mortality rate was 76%.
Candidemia is not only associated with high
mortality, but also increases morbidity, length of
hospitalization, and medical costs in hospitals and
ICUs. The estimated incidence was 4.6 bloodstream
infections per 10,000 admissions and 6%-11%
of all bloodstream infections (1). In recent years
candidemia incidence has been increasing, especially

in ICUs, due to advances in medical technology,
invasive procedures, and broad spectrum antibiotics
due to multi-drug resistant bacteria. The incidence
of candidemia increased during the 7-year period
in our ICUs, and 98% of these patients had at least
one nosocomial infection and antibiotic usage before
candidemia. The high incidence of nosocomial
infections and multi-drug resistant bacteria (4,5)
predispose for candidemia in our ICUs. Furthermore,
patients had had long hospital and ICU stays (22.62
± 16.45 and 19.78 ± 17.01, respectively) before
candidemia, probably due to these nosocomial
infections. The long stay and exposure to invasive
procedures and antibiotics impair the host defense
mechanisms of the patients. Moreover, TPN
solutions and attendant central venous catheters
altered cutaneous and gastrointestinal barriers that
predispose candida colonization and candidemia.
Ninety-one percent of our patients had central
venous access and 82% received TPN solutions. Prior
surgery, especially gastrointestinal surgery, is another
familiar risk factor for candidemia (1). Additionally,
61% of the patients had surgery and gastrointestinal
surgery comprised 64% of this group. Moreover,
most of our episodes were defined as primary, which
may reflect gastrointestinal colonization.
Unfortunately, Candida species were not observed
in 51% of the isolates in this study. However, C.
parapsilosis was as prevalent as C. albicans, which
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reflects the problems concerning infection control
measures in our ICUs. C. parapsilosis has different
epidemiologic features than other species, and can
occur without prior colonization. Furthermore,
this species is frequently transmitted horizontally
via contaminated external sources, such as medical
devices or fluids, the hands of healthcare workers,
prosthetic devices, and catheters.
The mortality rate of candidemia is still high
despite advances in drugs and range between 30% and
70% with 20%-50% attributable mortality. Moreover,
crude mortality rates were excessively high (76%)
in the present study. However, we did not use any

severity index. The high mortality rates may reflect
the severity of underlying diseases, rather than being
the direct consequence of candidemia as mentioned
in literature (1).
The study has some limitations: it is not a casecontrol study, colonization index was not evaluated,
and some data about patients and isolates were absent.
However, this study showed the threat beyond high
nosocomial infection rates and multi-drug resistant
bacteria. To control bacterial infections and other
risk factors in ICUs and to identify patients at highest
risk, using colonization index, for candidemia, and
prophylactic antifungal therapy may be a suitable
approach for preventing nosocomial candidemia.
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